Jan 19, 2009 | NEWS
Findings point to common mechanisms of susceptibility to cancers of the lung, bladder, prostate, cervix and skin; findings to be integrated into deCODEme™, the new deCODEme Cancer Scan™, and deCODE’s DNA-based risk diagnostic tests Reykjavik, ICELAND, January 19, 2009...
Jan 18, 2009 | NEWS
Focused Genetic Scans Offer Individuals a New Way to Better Understand their Risk of Cardiovascular Disease and Common Cancers Reykjavik, ICELAND, January 18, 2009 – Through deCODEme™, the world’s first first retail genome analysis service, deCODE genetics...
Jan 16, 2009 | NEWS
Reykjavik, ICELAND, January 16, 2009 – In a paper published today scientists at deCODE genetics (Nasdaq:DCGN) present the results of the largest study of ancient DNA from a single population ever undertaken. Analyzing mitochondrial DNA, which is passed from mother to...
Dec 15, 2008 | NEWS
Findings point to potential therapeutic pathways and provide widening basis for the development of a risk assessment test Reykjavik, ICELAND, December 15, 2008 – Scientists from deCODE genetics (Nasdaq:DCGN) and colleagues from Australia and Denmark today report the...
Dec 14, 2008 | NEWS
New genetic variants linked to obesity are being integrated into the deCODEme™ personal genome analysis service Reykjavik, ICELAND, December 14, 2008 – In one of the largest studies of its kind, a multinational team led by scientists from deCODE genetics (Nasdaq:DCGN)...
Dec 8, 2008 | NEWS
Reykjavik, ICELAND, December 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the human genome (SNP) that is...